The number after each drug is how many registered trials in our index test it, all years and all statuses. Each link opens the full list.
Top A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
- Radiotherapy (3,000 trials)
- Rituximab (2,165 trials)
- Radiosurgery (1,001 trials)
- Resistance Training (983 trials)
- Ropivacaine (946 trials)
- Radiation (881 trials)
- Ribavirin (771 trials)
- Rosuvastatin Calcium (707 trials)
- Ritonavir (604 trials)
- Radiotherapy, Intensity-Modulated (586 trials)
- Ranibizumab (526 trials)
- Rivaroxaban (483 trials)
- Restraint, Physical (466 trials)
- Remifentanil (455 trials)
- Rifampin (455 trials)
- Rehabilitation (451 trials)
- Risperidone (436 trials)
- Radiofrequency Ablation (360 trials)
- Rocuronium (239 trials)
- Raltegravir Potassium (229 trials)
- Rabeprazole (215 trials)
- Ringer's Lactate (203 trials)
- Root Planing (192 trials)
- Rifaximin (176 trials)
- Rosiglitazone (176 trials)
- Ramucirumab (172 trials)
- Referral and Consultation (171 trials)
- Ramipril (163 trials)
- Resveratrol (153 trials)
- Radiotherapy, Conformal (150 trials)
- Radiation Dose Hypofractionation (133 trials)
- Relaxation Therapy (125 trials)
- Roflumilast (112 trials)
- Respiration, Artificial (102 trials)
- Reverse Transcriptase Polymerase Chain Reaction (98 trials)
- Risedronic Acid (97 trials)
- Respiratory Function Tests (94 trials)
- Rilpivirine (91 trials)
- Ranolazine (86 trials)
- Riboflavin (83 trials)
- Respiratory Physiological Phenomena (76 trials)
- Range of Motion, Articular (75 trials)
- Rifabutin (74 trials)
- Riluzole (73 trials)
- RE1-silencing transcription factor (70 trials)
- RIX4414 vaccine (70 trials)
- Rivastigmine (69 trials)
- Robotic Surgical Procedures (69 trials)
- Raloxifene Hydrochloride (67 trials)
- Renal Dialysis (64 trials)
- Rabies Vaccines (60 trials)
- Ranitidine (59 trials)
- Registries (56 trials)
- Radiotherapy, Image-Guided (53 trials)
- Respiration (53 trials)
- Remote Patient Monitoring (48 trials)
- Rimonabant (47 trials)
- Racivir (46 trials)
- Radionuclide Imaging (43 trials)
- Rotavirus Vaccines (43 trials)
- R-CHOP protocol (42 trials)
- Receptor Protein-Tyrosine Kinases (39 trials)
- Radiotherapy, Adjuvant (38 trials)
- Respiratory Rate (37 trials)
- Retrospective Studies (36 trials)
- Rapid Diagnostic Tests (34 trials)
- Reference Standards (34 trials)
- Resistant Starch (34 trials)
- Risk Factors (34 trials)
- RotaTeq (34 trials)
- Random Allocation (31 trials)
- Radium-223 (30 trials)
- Renal Replacement Therapy (30 trials)
- Remote Consultation (29 trials)
- Reproductive Techniques, Assisted (27 trials)
- Rapeseed Oil (24 trials)
- Replantation (24 trials)
- Ringer's Solution (23 trials)
- Reboxetine (22 trials)
- Red Meat (22 trials)
- Razoxane (21 trials)
- Re-Irradiation (21 trials)
- Reproducibility of Results (21 trials)
- Robotics (21 trials)
- Risdiplam (19 trials)
- Risk Assessment (19 trials)
- Rubella Vaccine (19 trials)
- Radiomics (18 trials)
- Real-Time Polymerase Chain Reaction (18 trials)
- Reoperation (18 trials)
- Resuscitation (18 trials)
- RC48 antibody (17 trials)
- Running (17 trials)
- Radiography, Panoramic (16 trials)
- RG7388 (15 trials)
- Residence Characteristics (15 trials)
- RAD1901 (14 trials)
- RNA, Messenger (14 trials)
- RTS malaria vaccine (14 trials)
- Receptors, Chimeric Antigen (14 trials)
- R-1,1,1-trifluoro-4-(5-fluoro-2,3-dihydrobenzofuran-7-yl)-4-methyl-2-(((2-methyl-5-quinolyl)amino)methyl)pentan-2-ol (13 trials)
- RC-18 (13 trials)
- RNS60 (13 trials)
- RRx-001 (13 trials)
- Receptors, Interleukin-6 (13 trials)
- Respiratory Syncytial Virus Vaccines (13 trials)
- Respiratory Therapy (13 trials)
- Rutin (13 trials)
- Rogaratinib (12 trials)
- Rose Bengal (12 trials)
- RNA, Small Interfering (11 trials)
- Radionuclide Generators (11 trials)
- Recombivax HB (11 trials)
- Red Light (11 trials)
- Risk (11 trials)
- Radiopharmaceuticals (10 trials)
- Regimen B (10 trials)
- Relaxin (10 trials)
- Ribose (10 trials)
- Root Canal Therapy (10 trials)
- Rubidium-82 (10 trials)
- RG-1507 monoclonal antibody (9 trials)
- RT001 (9 trials)
- RZL-012 (9 trials)
- Reinforcement Machine Learning (9 trials)
- Reserpine (9 trials)
- Rezafungin (9 trials)
- Rice Bran Oil (9 trials)
- Root Canal Obturation (9 trials)
- Routinely Collected Health Data (9 trials)
- RNA (8 trials)
- Rehabilitation, Vocational (8 trials)
- Research Design (8 trials)
- Retinoids (8 trials)
- Rhinoplasty (8 trials)
- Ringer's acetate (8 trials)
- RID (7 trials)
- Radioimmunotherapy (7 trials)
- Randomized Controlled Trials as Topic (7 trials)
- Reaction Time (7 trials)
- Refraction, Ocular (7 trials)
- Refractive Surgical Procedures (7 trials)
- Resin Cements (7 trials)
- Return to Work (7 trials)
- Root Canal Preparation (7 trials)
- Roxithromycin (7 trials)
- RLS-0071 (6 trials)
- RO5126766 (6 trials)
- Raclopride (6 trials)
- Radio Frequency Identification Device (6 trials)
- Radioimmunodetection (6 trials)
- Receptors, Fc (6 trials)
- Refit milk powder (6 trials)
- Regeneration (6 trials)
- Reperfusion (6 trials)
- Replens (6 trials)
- Roscovitine (6 trials)
- RFB4(dsFv)-PE38 recombinant immunotoxin (5 trials)
- RNA-Seq (5 trials)
- RO6870810 (5 trials)
- RPX7009 (5 trials)
- RSLV-132 (5 trials)
- Radiography (5 trials)
- Rapid Sequence Induction and Intubation (5 trials)
- Receptor-Like Protein Tyrosine Phosphatases, Class 2 (5 trials)
- Records (5 trials)
- Remaxol (5 trials)